Literature DB >> 34327259

BPH nomogram using IPSS, prostate volume, peak flow rate, PSA and median lobe protrusion for predicting the need for intervention: development and internal validation.

Arvind P Ganpule1, Rohan S Batra1, Nitiraj B Shete1, Abhishek G Singh1, Ravindra B Sabnis1, Mahesh R Desai1.   

Abstract

OBJECTIVE: The aim of the present study was to develop a nomogram to accurately predict the need for intervention in patients suffering from LUTS due to benign prostatic hyperplasia (BPH) and internally validate it.
MATERIAL AND METHODS: The data was collected from the community subjects from the state of Gujarat in western India. All the demographic data, physical examination, PSA, uroflowmetry and prostatic ultrasound was collected in 92 subjects and were followed up after 2 years. The data was analyzed and logistic regression model was used to build a predictive model. A nomogram was build using R software. Nomogram was internally validated using 50 subjects.
RESULTS: 92 subjects were analyzed for developing the nomogram. Out of these, 17 patients needed intervention. 8 patients were started on medical therapy and 9 patients were taken up for surgical intervention. Of all the statistically significant predictors, peak flow rate was the most significant and was followed by median lobe enlargement, PSA, prostate volume and IPSS. These variables were used to develop a prediction model for the intervention required using reduced logistic regression model. The predictive accuracy of the model was 95.65% with a sensitivity of 88.28%, a specificity of 97.33%, a positive predictive value (PPV) of 88.24%, and a negative predictive value (NPV) of 97.33%. The AUC of the model was 0.799. Internal validation was done on 50 subjects which had sensitivity, specificity and AUC of the model at 89.66%, 90.48% and 0.968 respectively.
CONCLUSION: The study demonstrates the clinical application of nomogram which uses IPSS, PSA, peak flow rate, prostate volume and median lobe enlargement (intravesical prostatic volume). It has a sensitivity of 88.24%, specificity of 97.33%. It predicts the need for intervention in BPH patients with accuracy of 95.65% which was internally validated with an accuracy of 90%. AJCEU
Copyright © 2021.

Entities:  

Keywords:  BPH (Benign Prostatic Hyperplasia); intervention; intravesical prostatic protrusion; lower urinary tract symptoms (LUTS); nomogram; peak flow rate

Year:  2021        PMID: 34327259      PMCID: PMC8303027     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  19 in total

1.  Natural history of prostatism: risk factors for acute urinary retention.

Authors:  S J Jacobsen; D J Jacobson; C J Girman; R O Roberts; T Rhodes; H A Guess; M M Lieber
Journal:  J Urol       Date:  1997-08       Impact factor: 7.450

2.  Drawing Nomograms with R: applications to categorical outcome and survival data.

Authors:  Zhongheng Zhang; Michael W Kattan
Journal:  Ann Transl Med       Date:  2017-05

3.  Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

Authors:  C G Roehrborn; J D McConnell; M Lieber; S Kaplan; J Geller; G H Malek; R Castellanos; S Coffield; B Saltzman; M Resnick; T J Cook; J Waldstreicher
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

4.  Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms.

Authors:  G S Steele; M P Sullivan; D J Sleep; S V Yalla
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

5.  Relationships between Prostatic Volume and Intravesical Prostatic Protrusion on Transabdominal Ultrasound and Benign Prostatic Obstruction in Patients with Lower Urinary Tract Symptoms.

Authors:  Delin Wang; Honghong Huang; Yan Mee Law; Keong Tatt Foo
Journal:  Ann Acad Med Singapore       Date:  2015-02       Impact factor: 2.473

6.  Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness--new standards for noninvasive bladder outlet obstruction diagnosis?

Authors:  Giorgio Franco; Cosimo De Nunzio; Costantino Leonardo; Andrea Tubaro; Mauro Ciccariello; Carlo De Dominicis; Lucio Miano; Cesare Laurenti
Journal:  J Urol       Date:  2010-04-18       Impact factor: 7.450

7.  Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.

Authors:  C G Roehrborn; P Boyle; D Bergner; T Gray; M Gittelman; T Shown; A Melman; R B Bracken; R deVere White; A Taylor; D Wang; J Waldstreicher
Journal:  Urology       Date:  1999-10       Impact factor: 2.649

8.  Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.

Authors:  S J Jacobsen; C J Girman; H A Guess; T Rhodes; J E Oesterling; M M Lieber
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

9.  Alcohol, Smoking, Physical Activity, Protein, and Lower Urinary Tract Symptoms: Prospective Longitudinal Cohort.

Authors:  Min Soo Choo; Jun Hyun Han; Tae Young Shin; Kyungtae Ko; Won Ki Lee; Sung Tae Cho; Sang Kon Lee; Seong Ho Lee
Journal:  Int Neurourol J       Date:  2015-09-22       Impact factor: 2.835

10.  Development and validation of a clinical nomogram predicting bladder outlet obstruction via routine clinical parameters in men with refractory nonneurogenic lower urinary tract symptoms.

Authors:  Young Ju Lee; Jung Keun Lee; Jung Jun Kim; Hak Min Lee; Jong Jin Oh; Sangchul Lee; Sang Wook Lee; Jeong Hyun Kim; Seong Jin Jeong
Journal:  Asian J Androl       Date:  2019 Sep-Oct       Impact factor: 3.285

View more
  1 in total

1.  A Novel Nomogram Based on Initial Features to Predict BPH Progression.

Authors:  Lorenzo G Luciani; Daniele Mattevi; Daniele Ravanelli; Umberto Anceschi; Guido Giusti; Tommaso Cai; Umberto Rozzanigo
Journal:  Int J Environ Res Public Health       Date:  2022-08-08       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.